Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hubei Jinghong Chemical is a Chinese chemical manufacturing company specializing in the production of fine chemicals and pharmaceutical intermediates. Based in Jingmen, Hubei Province, the company is a prominent producer of 1,3-Dimethyl-2-imidazolidinone (DMI), a high-performance solvent used in the synthesis of active pharmaceutical ingredients (APIs) and agrochemicals. Their product portfolio also includes heterocyclic compounds and biocides like 1,2-Benzisothiazolin-3-one (BIT). The company operates industrial-scale manufacturing facilities and serves a global clientele in the life sciences and specialty chemical sectors. Hubei Jinghong Chemical is recognized for its focus on high-purity chemical synthesis and its role as a key supplier in the pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hubei Jinghong Chemical.